Document is current

Article History

Received: 23 May 2025

Accepted: 29 June 2025

First Online: 26 August 2025

Declarations

:

: BP is a consultant for Boston Scientific, Medtronic, Intuitive, Pierre Fabre, IBSA, Coloplast, Convatec, schwa medico, Hollister, AbbVie, Ipsen. BMB is a speaker for AbbVie, Axonics and Sumitomo Pharma, an investigator for AbbVie and Provepharm, and an advisor for Sumitomo Pharma, AbbVie, Medtronic and Watkins Conti. CDN is a speaker and consultant for Pierre Fabre, Ipsen, Janssen, Bayer, Accord and Idipharma. CG has received grants/research support from Astellas Pharma, Bayer, GSK, MSD and Recordati, and honoraria/consultation fees from Amgen, Astellas Pharma, Bayer, GSK, Ipsen, Janssen, Lilly Pharma, Medac, Novartis, Pierre Fabre, Recordati, Pfizer, Rottapharm and STEBA Biotech. JH is an investigator, speaker and consultant for, and received grants from, Astellas, Pierre Fabre, Medtronic, BlueWind and Eli Lilly. MCM has received consultancy or lecturer honoraria in the field of functional urology from Apogepha, Astellas, Biohaven, Dr. Willmar Schwabe, MiP Pharma and Pierre Fabre. MS is a speaker and consultant for, and received grants from, Pierre Fabre, Laborie and Coloplast. DS is an investigator, advisor and speaker for Sumitomo Pharma America and a speaker for Pierre-Fabre Medicament. CC is a consultant and speaker for Pierre Fabre, consultant to Pelvisure, and past consultant and speaker during the development of many compounds used for the treatment of OAB. MS is a speaker and consultant for, and received grants from, Pierre Fabre, Laborie and Coloplast. DS is an investigator, advisor and speaker for Sumitomo Pharma America and a speaker for Pierre-Fabre Medicament. CC is a consultant and speaker for Pierre Fabre, consultant to Pelvisure, and past consultant and speaker during the development of many compounds used for the treatment of OAB.